Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study
Aging Clinical and Experimental Research · 2024
DOI: 10.1007/s40520-024-02804-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Aging Clinical and Experimental Research, 2024. Verfasst von Muhammer Ergenç und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Marmara University School of Medicine, Başıbüyük Campus Başıbüyük Mah. Maltepe Başıbüyük Yolu Sok. No: 9/2 Maltepe 348…. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Pancreatic Neoplasms, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to compare the postoperative outcomes of < 75-year-old patients and ≥ 75-year-old patients who underwent pancreaticoduodenectomy (PD) for pancreatic head and periampullary region tumors.
Methods
Patients who underwent PD in our hospital between February 2019 and December 2023 were evaluated. Demographics, Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scores, American Society of Anesthesiologists (ASA) scores, comorbidities, hospital stays, complications, and clinicopathological features were analyzed. Patients were divided into < 75 years (Group A) and ≥ 75 years (Group B) groups and compared.
Results
The median age of the entire cohort (n = 155) was 66 years (IQR = 16). There was a significant difference between Group A (n = 128) and Group B (n = 27) regarding the ECOG-PS and ASA scores. There was no significant difference between the groups regarding postoperative complications. The 30-day mortality rate was greater in Group B (p = 0.017). Group B had a cumulative median survival of 10 months, whereas Group A had a median survival of 28 months, with a statistically significant difference (p < 0.001). When age groups were stratified according to ECOG-PS, for ECOG-PS 2–3 Group A, survival was 15 months; for ECOG-PS 2–3 Group B, survival was eight months, and the difference was not statistically significant (p = 0.628).
Conclusions
With the increasing aging population, patient selection for PD should not be based solely on age. This study demonstrated that PD is safe for patients older than 75 years. In older patients, performance status and the optimization of comorbidities should be considered when deciding on a candidate’s suitability for surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Marmara University School of Medicine, Başıbüyük Campus Başıbüyük Mah. Maltepe Başıbüyük Yolu Sok. No: 9/2 Maltepe 34854, Istanbul, Turkey. muhammer.ergenc@marmara.edu.tr.
- Department of General Surgery, Marmara University School of Medicine, Başıbüyük Campus Başıbüyük Mah. Maltepe Başıbüyük Yolu Sok. No: 9/2 Maltepe 34854, Istanbul, Turkey.
- Department of General Surgery, Hınıs Şehit Yavuz Yürekseven State Hospital, Yenikent Mahallesi Cumhuriyet Caddesi No:7/4 Hınıs, 25600, Erzurum, Turkey.
Zitieren
APA
Ergenç, M., Uprak, T. K., Özocak, A. B., Karpuz, Ş., Coşkun, M., Yeğen, C., & Atıcı, A. E. (2024). Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-024-02804-9
Vancouver
Ergenç M, Uprak TK, Özocak AB, Karpuz Ş, Coşkun M, Yeğen C, et al. Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study. Aging Clinical and Experimental Research. 2024. doi:10.1007/s40520-024-02804-9
BibTeX
@article{Ergen2024,
author = {Ergenç, Muhammer and Uprak, Tevfik Kıvılcım and Özocak, Ayşegül Bahar and Karpuz, Şakir and Coşkun, Mümin and Yeğen, Cumhur and Atıcı, Ali Emre},
title = {Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study},
journal = {Aging Clinical and Experimental Research},
year = {2024},
doi = {10.1007/s40520-024-02804-9}
}
EUVIMED